Langsung ke konten

Langsung ke menu sekunder

Saksi-Saksi Yehuwa

Indonesia

Analisis Biaya untuk Alternatif Transfusi Darah

Hematologi (Onkologi)

Should intravenous iron be the standard of care in oncology?

Auerbach M.

Sumber‎: J Clin Oncol 2008;26(10):1579-81.

Indexed‎: PubMed 18375888

DOI‎: 10.1200/JCO.2007.15.4609

http://www.ncbi.nlm.nih.gov/pubmed/18375888

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.

Borg S, Glenngård AH, Osterborg A, Persson U.

Sumber‎: Acta Oncol 2008;47(6):1009-17.

Indexed‎: PubMed 18770060

DOI‎: 10.1080/02841860701744498

http://www.ncbi.nlm.nih.gov/pubmed/18770060

Cost of outpatient blood transfusion in cancer patients.

Crémieux PY, Barrett B, Anderson K, Slavin MB.

Sumber‎: J Clin Oncol 2000;18(14):2755-61.

Indexed‎: PubMed 10894876

http://www.ncbi.nlm.nih.gov/pubmed/10894876

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe.

Deger M, Eisterer W, Kutikova L, Salek S.

Sumber‎: Support Care Cancer 2013;21(2):485-93.

Indexed‎: PubMed 22825456

DOI‎: 10.1007/s00520-012-1538-0

http://www.ncbi.nlm.nih.gov/pubmed/22825456

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom.

Guest JF, Watson HG, Limaye S.

Sumber‎: Clin Ther 2010;32(14):2478-93.

Indexed‎: PubMed 21353116

DOI‎: 10.1016/j.clinthera.2011.01.011

http://www.ncbi.nlm.nih.gov/pubmed/21353116

Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation.

Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE.

Sumber‎: Biol Blood Marrow Transplant 2012;18(5):813-7.

Indexed‎: PubMed 22080050

DOI‎: 10.1016/j.bbmt.2011.10.043

http://www.ncbi.nlm.nih.gov/pubmed/22080050

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Sumber‎: Cancer 2013;119(1):107-14.

Indexed‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

http://www.ncbi.nlm.nih.gov/pubmed/22744794

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece.

Nikolaidi E, Hatzikou M, Geitona M.

Sumber‎: Cost Eff Resour Alloc 2013;11(1):16.

Indexed‎: PubMed 23870502

DOI‎: 10.1186/1478-7547-11-16

http://www.ncbi.nlm.nih.gov/pubmed/23870502

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia.

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Sumber‎: Support Care Cancer 2012;20(1):159-65.

Indexed‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

http://www.ncbi.nlm.nih.gov/pubmed/21359879

The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA).

Reitan JF, Kudrik FJ, Fox K, van Breda A, Shreay S, Corey-Lisle PK.

Sumber‎: J Med Econ 2013;16(5):633-8.

Indexed‎: PubMed 23425291

DOI‎: 10.3111/13696998.2013.778269

http://www.ncbi.nlm.nih.gov/pubmed/23425291

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction.

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Sumber‎: Transfusion 2010;50(2):487-92.

Indexed‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

http://www.ncbi.nlm.nih.gov/pubmed/19804569

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.

Stallworth JR, Jerrell JM, Tripathi A.

Sumber‎: Am J Hematol 2010;85(10):795-7.

Indexed‎: PubMed 20645429

DOI‎: 10.1002/ajh.21772

http://www.ncbi.nlm.nih.gov/pubmed/20645429


Bagian medis pada jw.org ini dirancang sebagai sumber informasi yang umumnya digunakan oleh dokter dan tenaga medis profesional lainnya. Tapi bagian ini tidak menyediakan nasihat medis atau menyarankan perawatan tertentu dan bukan pengganti suatu perawatan kesehatan yang memadai. Lektur kedokteran yang dikutip bukan diterbitkan oleh Saksi-Saksi Yehuwa, tetapi lektur itu membahas strategi alternatif-transfusi yang perlu dipertimbangkan. Tiap-tiap dokter bertanggung jawab untuk selalu mendapatkan informasi terkini, membahas pilihan perawatan, dan membantu pasien membuat pilihan yang sesuai dengan keadaan medis, keinginan, nilai-nilai, dan kepercayaan mereka. Tidak semua strategi yang disebutkan ini cocok dan berterima bagi setiap pasien.

Pasien: Carilah selalu nasihat dokter tentang keadaan dan pengobatan Anda. Periksalah ke dokter jika Anda merasa sakit.

Penggunaan website ini diatur oleh persyaratan penggunaan.